A novel and efficient approach to highly substituted indolizines via 5-endo-trig iodocyclization

Tetrahedron

Volumn 63, Issue 52, 2007, Pages 12954-12960

  Kim, Ikyon ^a   Won, Hye Kyoung ^a   Choi, Jihyun ^a   Lee, Ge Hyeong ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

5 endo trig Iodocyclization; Environmentally benign; Indolizine; Iodine

Indexed keywords

(4 (PROP 1 EN 2 YL)CYCLOHEX 1 ENYL)(PYRIDIN 2 YL)METHYL ACETATE; 1 (PYRIDIN 2 YL)BUT 2 ENYL ACETATE; 1 (PYRIDIN 2 YL)HEX 2 ENYL ACETATE; 1,2,3,4 TETRAHYDROPYRIDOL[1,2 A]INDOL 10 YL ACETATE; 2 METHYL 1 (3 METHYLPYRIDIN 2 YL) 3 PHENYL ALLYL ACETATE; 2 METHYL 1 (5 METHYLPYRIDIN 2 YL) 3 PHENYL ALLYL ACETATE; 2 METHYL 1 (PYRIDIN 2 YL)ALLYL ACETATE; 2 METHYL 1 (PYRIDIN 2 YL)PENT 2 ENYL ACETATE; 2 METHYL 1(PYRIDIN 2 YL)BUT 2 ENYL ACETATE; 2 METHYL 3 PHENYL 1 (PYRIDIN 2 YL)ALLYL ACETATE; 2 METHYL 3 PHENYLINDOLIZIN 1 YL ACETATE; 2,3 DIMETHYLINDOLIZIN 1 YL ACETATE; 2,4 DIPHENYL 1 (PYRIDIN 2 YL)BUT 2 ENYL ACETATE; 2,6 DIMETHYL 3 PHENYLINDOLIZIN 1 YL ACETATE; 2,8 DIMETHYL 3 PHENYLINDOLIZIN 1 YL ACETATE; 3 (2 METHOXYPHENYL) 1 (PYRIDIN 2 YL)ALLYL ACETATE; 3 (2 METHOXYPHENYL)INDOLIZIN 1 YL ACETATE; 3 (2 NITROPHENYL) 1 (PYRIDIN 2 YL)ALLYL ACETATE; 3 (2 NITROPHENYL)INDOLIZIN 1 YL ACETATE; 3 (FURAN 2 YL) 1 (PYRIDIN 2 YL)ALLYL ACETATE; 3 (FURAN 2 YL)INDOLIZIN 1 YL ACETATE; 3 (PROP 1 EN 2 YL) 1,2,3,4 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL ACETATE; 3 BENZYL 2 PHENYLINDOLIZIN 1 YL ACETATE; 3 ETHYL 2 METHYLINDOLIZIN 1 YL ACETATE; 3 METHYLINDOZOLIZIN 1 YL ACETATE; 3 PHENYL 1 (PYRIDIN 2 YL)ALLYL ACETATE; 3 PHENYLINDOLIZIN 1 YL ACETATE; 3 PROPYLINDOLIZIN 1 YL ACETATE; CYCLOHEXYL(PYRIDIN 2 YL)METHYL ACETATE; INDOLIZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; IODINATION; ISOMERIZATION; PRIORITY JOURNAL; SUBSTITUTION REACTION;

EID: 36148978567     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.10.037     Document Type: Article

References (48)

1. For general reviews, see:
2. Shipman M. Sci. Synth. 10 (2001) 745
3. Michael J.P. Nat. Prod. Rep. 17 (2000) 579
4. Grundon M.F. Nat. Prod. Rep. 6 (1989) 523
5. Flitsch W. In: Katritzky A.R., and Rees C.W. (Eds). Comprehensive Heterocyclic Chemistry Vol. 4 (1984), Pergamon, Oxford 443
6. Uchida T., and Matsumoto K. Synthesis 4 (1976) 209
7. Gundersen L.-L., Charnock C., Negussie A.H., Rise F., and Teklu S. Eur. J. Pharm. Sci. 30 (2007) 26
8. Hynd, G.; Ray, N. C.; Finch, H.; Montana, J. G.; Cramp, M. C.; Harrison, T. K.; Arienzo, R.; Blaney, P.; Griffon, Y.; Middlemiss, D. WO 2007031747 A1, 2007;
9. Millet R., Domarkas J., Rigo B., Goossens L., Goossens J.-F., Houssin R., and Henichart J.-P. Bioorg. Med. Chem. 10 (2002) 2905
10. Sonnet P., Dallemagne P., Guillon J., Enguehard C., Stiebing S., Tanguy J., Bureau R., Rault S., Auvray P., Moslemi S., Sourdaine P., and Seralini G.-E. Bioorg. Med. Chem. 8 (2000) 945
11. Hagishita S., Yamada M., Shirahase K., Okada T., Murakami Y., Ito Y., Matsuura T., Wada M., Kato T., Ueno M., Chikazawa Y., Yamada K., Ono T., Teshirogi I., and Ohtani M. J. Med. Chem. 39 (1996) 3636
12. Gubin J., de Vogelaer H., Inion H., Houben C., Lucchetti J., Mahaux J., Rosseels G., Peiren M., Clinet M., Polster P., and Chatelain P. J. Med. Chem. 36 (1993) 1425
13. Jaffrezou J.P., Levade T., Thurneyssen O., Chiron M., Bordier C., Attal M., Chatelain P., and Laurent G. Cancer Res. 52 (1992) 1352
14. Cingolani G.M., Claudi F., Massi M., and Venturi F. Eur. J. Med. Chem. 25 (1990) 709
15. Surpateanu G.G., Becuwe M., Lungu N.C., Dron P.I., Fourmentin S., Landy D., and Surpateanu G. J. Photochem. Photobiol., A 185 (2007) 312
16. Delattre F., Woisel P., Surpateanu G., Cazier F., and Blach P. Tetrahedron 61 (2005) 3939
17. Retaru A.V., Druta L.D., Deser T., and Mueller T.J. Helv. Chim. Acta 88 (2005) 1798
18. Sonnenschein H., Henrich G., Resch-Genger V., and Schulz B. Dyes Pigments 46 (2000) 23
19. Saeva F.D., and Luss H.R. J. Org. Chem. 53 (1988) 1804
20. For recent examples, see:
21. Schwier T., Sromek A.W., Yap D.M.L., Chernyak D., and Gevorgyan V. J. Am. Chem. Soc. 129 (2007) 9868
22. Seregin I.V., Schammel A.W., and Gevorgyan V. Org. Lett. 9 (2007) 3433
23. Chuprakov S., Hwang F.W., and Gevorgyan V. Angew. Chem., Int. Ed. 46 (2007) 4757
24. El Kaim L., Gizolme M., and Grimaud L. Synlett (2007) 227
25. Smith C.R., Bunnelle E.M., Rhodes A.J., and Sarpong R. Org. Lett. 9 (2007) 1169
26. Liu Y., Hu H.-Y., Liu Q.-J., Hu H.-W., and Xu J.-H. Tetrahedron 63 (2007) 2024
27. Marchalín S., Žúžiová J., Kadlečíková K., Šafář P., Baran P., Dalla V., and Daïch A. Tetrahedron Lett. 48 (2007) 697
28. Seregin I.V., and Gevorgyan V. J. Am. Chem. Soc. 128 (2006) 12050
29. Kaloko Jr. J., and Hayford A. Org. Lett. 7 (2005) 4305
30. Kel'in A.V., Sromek A.W., and Gevorgyan V. J. Am. Chem. Soc. 123 (2001) 2074
31. Padwa A., Austin D.J., Precedo L., and Zhi L. J. Org. Chem. 58 (1993) 1144
32. Kim I., Choi J., Won H.K., and Lee G.H. Tetrahedron Lett. 48 (2007) 6863
33. Kim I., Lee G.H., and No Z.S. Bull. Korean Chem. Soc. 28 (2007) 685
34. For recent reviews on iodocyclizations, see:
35. Togo H., and Iida S. Synlett (2006) 2159
36. Martins da Silva F., Jones Jr. J., and de Mattos M.C.S. Curr. Org. Synth. 2 (2005) 393
37. For selected examples on 5-endo-trig iodocyclizations, see:
38. Amjad M., and Knight D.W. Tetrahedron Lett. 47 (2006) 2825
39. Donohue T.J., Sintim H.O., and Hollinshead J. J. Org. Chem. 70 (2005) 7297
40. Knight D.W., Shaw D.E., and Staples E.R. Eur. J. Org. Chem. (2004) 1973
41. Knight D.W., and Staples E.R. Tetrahedron Lett. 43 (2002) 6771
42. Bedford S.B., Bell K.E., Bennett F., Hayes C.J., Knight D.W., and Shaw D.E. J. Chem. Soc., Perkin Trans 1 (1999) 2143
43. Barks J.M., Knight D.W., Seaman C.J., and Weingarten G.G. Tetrahedron Lett. 35 (1994) 7259
44. Kang S.H., and Lee S.B. Tetrahedron Lett. 34 (1993) 7579
45. Kang S.H., and Lee S.B. Tetrahedron Lett. 34 (1993) 1955
46. The relative stereochemistry of these diastereomers was not determined.
47. Similarly, exposure of propargylic acetate a to iodine failed to deliver the indolizine b, only yielding a complex mixture. Unpublished results.{A figure is presented}
48. A pyridine group was first used as an internal nucleophilic partner in iodocyclizations by us. See Ref. 5a.